📍 ENTRY: $29.30
🛑 **STOP LOSS:** $27.80 (Risk: $1.50)
🎯 **TAKE PROFIT:** $32.24 (Reward: $2.94)
📊 R:R RATIO: ~1:1.96
🔍 TECHNICAL ANALYSIS (The Setup):
HOMB is currently trading near $29.30**, approaching a **key resistance zone** around **$29.20-$29.33.
The stock has a 52-week high of $30.83** and a **52-week low of $25.50.
My entry at $29.30 is positioned just above this resistance, anticipating a breakout toward the 52-week high.
The stop loss at $27.80** is placed safely below the **200 SMA ($27.5) and key support levels in the $27.76-$28.03 zone, giving the trade room to breathe while protecting against a false breakdown.
**Target at $32.24**: This aligns with the **upper end of analyst price targets** ($33.00 high) and represents a logical projection if the market continues to price in the bank's superior fundamentals.
Technical indicators: RSI at 62.8 (neutral, room to run), MACD line above signal line indicating bullish momentum.
📊 FUNDAMENTAL ANALYSIS (The Catalyst):
HOMB reports Q2 2026 earnings after the close TODAY (July 15). Expectations are solid:
✅ Consensus EPS: $0.61-$0.62 vs. $0.60 in Q1 2026.
✅ **Consensus Revenue: ~$289M**, up from $273.6M in Q2 2025 (+5.7%).
Q1 2026 results show a top-tier regional bank:
✅ Net income of $118.2M** with **EPS of $0.60.
✅ ROA of 2.09% and ROTCE of 16.56% — well above industry averages.
✅ NIM of 4.51%, reflecting strong earning asset yields.
✅ PPNR of $152.7M, demonstrating consistent operational strength.
The market punished HOMB after Q1 earnings (-3.36% in one day) due to a slight revenue miss. This created a buying opportunity ahead of what analysts expect to be a rebound quarter.
Analyst consensus: 7 analysts with an average 12-month price target of **$31.14** (range $29-$33), implying a ~7.4% upside.
🎯 TRADE STRATEGY:
Entry at $29.30: Entering as the stock approaches resistance, anticipating a breakout post-earnings if results meet or exceed expectations.
SL at $27.80: Below the 200 SMA and key support, protecting against a bearish reversal.
**TP at $32.24:** Approaching the highest analyst target ($33), capturing the full upside of a positive earnings reaction.
⚠️ RISK MANAGEMENT:
Earnings risk: The stock dropped -3.36% after Q1 earnings despite an EPS beat. A similar "sell-the-news" reaction could occur if the market focuses on margin compression or the $110M non-performing credit in Texas.
Macro headwinds: The stable rate environment has eased funding costs but also pressured net interest income.
Technical caution: A MACD Death Cross was triggered on the 15-minute chart on July 7, suggesting potential short-term weakness — hence the importance of a disciplined stop loss.
💬 What are your thoughts? Is anyone else positioning for HOMB earnings today, or do you expect a post-earnings dip like last quarter?
⚠️ DISCLAIMER:
This is NOT financial or investment advice. This post reflects my personal opinion and analysis based on publicly available information. Trading and investing involve substantial risk, including the potential loss of your entire capital. Past performance does not guarantee future results. Always do your own research (DYOR) and consult with a licensed financial advisor before making any trading decisions. I am not responsible for any losses incurred.
🛑 **STOP LOSS:** $27.80 (Risk: $1.50)
🎯 **TAKE PROFIT:** $32.24 (Reward: $2.94)
📊 R:R RATIO: ~1:1.96
🔍 TECHNICAL ANALYSIS (The Setup):
HOMB is currently trading near $29.30**, approaching a **key resistance zone** around **$29.20-$29.33.
The stock has a 52-week high of $30.83** and a **52-week low of $25.50.
My entry at $29.30 is positioned just above this resistance, anticipating a breakout toward the 52-week high.
The stop loss at $27.80** is placed safely below the **200 SMA ($27.5) and key support levels in the $27.76-$28.03 zone, giving the trade room to breathe while protecting against a false breakdown.
**Target at $32.24**: This aligns with the **upper end of analyst price targets** ($33.00 high) and represents a logical projection if the market continues to price in the bank's superior fundamentals.
Technical indicators: RSI at 62.8 (neutral, room to run), MACD line above signal line indicating bullish momentum.
📊 FUNDAMENTAL ANALYSIS (The Catalyst):
HOMB reports Q2 2026 earnings after the close TODAY (July 15). Expectations are solid:
✅ Consensus EPS: $0.61-$0.62 vs. $0.60 in Q1 2026.
✅ **Consensus Revenue: ~$289M**, up from $273.6M in Q2 2025 (+5.7%).
Q1 2026 results show a top-tier regional bank:
✅ Net income of $118.2M** with **EPS of $0.60.
✅ ROA of 2.09% and ROTCE of 16.56% — well above industry averages.
✅ NIM of 4.51%, reflecting strong earning asset yields.
✅ PPNR of $152.7M, demonstrating consistent operational strength.
The market punished HOMB after Q1 earnings (-3.36% in one day) due to a slight revenue miss. This created a buying opportunity ahead of what analysts expect to be a rebound quarter.
Analyst consensus: 7 analysts with an average 12-month price target of **$31.14** (range $29-$33), implying a ~7.4% upside.
🎯 TRADE STRATEGY:
Entry at $29.30: Entering as the stock approaches resistance, anticipating a breakout post-earnings if results meet or exceed expectations.
SL at $27.80: Below the 200 SMA and key support, protecting against a bearish reversal.
**TP at $32.24:** Approaching the highest analyst target ($33), capturing the full upside of a positive earnings reaction.
⚠️ RISK MANAGEMENT:
Earnings risk: The stock dropped -3.36% after Q1 earnings despite an EPS beat. A similar "sell-the-news" reaction could occur if the market focuses on margin compression or the $110M non-performing credit in Texas.
Macro headwinds: The stable rate environment has eased funding costs but also pressured net interest income.
Technical caution: A MACD Death Cross was triggered on the 15-minute chart on July 7, suggesting potential short-term weakness — hence the importance of a disciplined stop loss.
💬 What are your thoughts? Is anyone else positioning for HOMB earnings today, or do you expect a post-earnings dip like last quarter?
⚠️ DISCLAIMER:
This is NOT financial or investment advice. This post reflects my personal opinion and analysis based on publicly available information. Trading and investing involve substantial risk, including the potential loss of your entire capital. Past performance does not guarantee future results. Always do your own research (DYOR) and consult with a licensed financial advisor before making any trading decisions. I am not responsible for any losses incurred.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.